Medical Weight Loss & Management | Sherman, TX

Semaglutide, under the brand name Wegovy, is an FDA-approved once-weekly injectable medication for weight loss.

Semaglutide mimics a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. It also regulates insulin and blood sugar imbalance, a common cause of difficulty in losing weight. Semaglutide mainly affects appetite, decreasing calorie intake and lowering body weight. People on semaglutide could achieve weight reductions of up to 15%.

“Semaglutide indicated a significant weight loss with an acceptable safety for obese or overweight patients without diabetes.”

“Semaglutide (injected or oral) has superior efficacy compared with placebo and other antidiabetic medications in weight reduction….”

“In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.” 

Tirzepatide, under the brand name Mounjaro, is another once-weekly injectable medication for weight loss.

Tirzepatide mimics two hormones called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Being able to activate both the GLP-1 and GIP receptors, tirzepatide has been shown to decrease food intake and increases energy expenditure at the same time, which aids in weight loss. People on tirzepatide at the highest doses lost an average of 22.5% of their body weight.

During our highly effective, revolutionary once-weekly injection treatment program, our Team at One Family Clinic in Sherman will guide patients on realistic and sustainable lifestyle changes to boost and maintain weight loss.